Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parratt

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
European Heart Journal|July 1, 1986
Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?J R Parratt
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 28, 1998
Nitric oxide. A key mediator in sepsis and endotoxaemia?J R Parratt
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Nitric oxide in sepsis and endotoxaemiaJ R Parratt
Cardiovascular Drugs and Therapy|May 1, 1988
Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactionsJ R Parratt
Cardiovascular Research|April 1, 1993
The discovery of ischaemic preconditioningJ R Parratt
Lancet (London, England)|February 21, 1981
Oxyfedrine as an antianginal agentJ R Parratt
Heart (British Cardiac Society)|January 1, 1998
Delayed protection against ventricular arrhythmias by cardiac pacingJ R Parratt, A Vegh
British Journal of Haematology|May 12, 1998
Direct activation of factor X by monocytes occurs during cardiopulmonary bypassR Parratt, B J Hunt
History of Psychiatry|February 26, 2009
"How fury and lucid intervals may be proven" by Sir George Mackenzie of RosehaughE Miller, D R pARRATT
Cardiovascular Research|June 14, 2002
Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogsAgnes Végh, James R Parratt
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
European Heart Journal|July 1, 1986
Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?J R Parratt
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 28, 1998
Nitric oxide. A key mediator in sepsis and endotoxaemia?J R Parratt
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Nitric oxide in sepsis and endotoxaemiaJ R Parratt
Cardiovascular Drugs and Therapy|May 1, 1988
Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactionsJ R Parratt
Cardiovascular Research|April 1, 1993
The discovery of ischaemic preconditioningJ R Parratt
Lancet (London, England)|February 21, 1981
Oxyfedrine as an antianginal agentJ R Parratt
Heart (British Cardiac Society)|January 1, 1998
Delayed protection against ventricular arrhythmias by cardiac pacingJ R Parratt, A Vegh
British Journal of Haematology|May 12, 1998
Direct activation of factor X by monocytes occurs during cardiopulmonary bypassR Parratt, B J Hunt
History of Psychiatry|February 26, 2009
"How fury and lucid intervals may be proven" by Sir George Mackenzie of RosehaughE Miller, D R pARRATT
Cardiovascular Research|June 14, 2002
Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogsAgnes Végh, James R Parratt
Pageof 28